Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis of E7/Rb associations.

Sandra Caldeira1, Wen Dong, Massimo Tommasino

  • 1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

Methods in Molecular Medicine
|December 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying TERT promoter mutations in tumor-derived DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinoma.

Frontiers in oncology·2026
Same author

Oral Viral DNA Profiling in Obesity, Adenomatous Polyposis, and Colorectal Cancer Identifies Human β-Papillomavirus Types as Potentially Sex-Related and Modifiable Cancer Risk Indicators.

Cancers·2025
Same author

Interactome of the oncogenic ΔNp73α isoform in human papillomavirus 38 E6/E7-transformed keratinocytes.

Microbiology resource announcements·2025
Same author

HPV Biomarkers in Oral and Blood-Derived Body Fluids in Head and Neck Cancer Patients.

Journal of medical virology·2025
Same author

Association of opium use and tobacco smoking with α-, β-, and γ-human papillomavirus oral infection.

International journal of cancer·2024
Same author

Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration.

Virology·2024
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Human papillomaviruses (HPVs) E7 protein targets the retinoblastoma protein (pRb), a key cell-cycle regulator. This study presents methods to measure how efficiently different HPV E7 proteins neutralize pRb functions.

Area of Science:

  • Oncogenic viral proteins
  • Cell cycle regulation
  • Tumor suppressor pathways

Background:

  • Early gene E7 is a key transforming protein in human papillomaviruses (HPVs).
  • E7 protein alters cellular functions controlling proliferation and apoptosis.
  • E7 from HPV type 16 degrades the tumor-suppressor retinoblastoma protein (pRb), disrupting cell-cycle control.

Purpose of the Study:

  • To present methods for measuring the efficiency of E7 proteins from various HPV types in neutralizing pRb functions.
  • To compare the pRb-binding affinity and cellular pathway impact of different HPV E7 proteins.

Main Methods:

  • Plate-binding assay to determine pRb binding affinity of E7 proteins.
  • Intact cell-based assay to analyze the impact of E7 on the pRb pathway.

Related Experiment Videos

  • Utilizing the ubiquitin pathway for pRb degradation by E7.
  • Main Results:

    • E7 binding and pRb degradation are crucial for HPV oncogenic potential.
    • The efficiency of E7 in targeting pRb varies among different HPV types.
    • Methods allow for quantitative assessment of E7-pRb interaction and functional consequences.

    Conclusions:

    • The efficiency of E7 in neutralizing pRb dictates the oncogenic potential of HPV types.
    • Developed methods provide valuable tools for studying HPV E7 oncoprotein function.
    • Understanding E7-pRb interactions is critical for developing targeted HPV therapies.